Clinical Trials · NCT02249871
Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 54
- Start date
- Sep 2014
- Locations
- 1 site, Germany
- Primary endpoint
- Area under the semaglutide plasma concentration time curve